Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis-Reference-Cited by-同舟云学术

Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis

Published:2008-08-15 Issue:4 Volume:113 Page:723-732
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Matei Daniela,Emerson Robert E.,Schilder Jeanne,Menning Nancy,Baldridge Lee Ann,Johnson Cynthia S.,Breen Tim,McClean John,Stephens Doyle,Whalen Charles,Sutton Gregory

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference52 articles.

1. Cancer statistics, 2000;Greenlee;CA Cancer J Clin.,2000

2. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan;Gordon;J Clin Oncol.,2001

3. Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group;Bookman;J Clin Oncol.,2003

4. Two classes of PDGF receptor recognize different isoforms of PDGF;Hart;Science.,1988

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and molecular features of platinum resistance in ovarian cancer;Critical Reviews in Oncology/Hematology;2024-09

2. The impact of treatment-induced dysgeusia on the nutritional status of cancer patients;Clinical Nutrition Open Science;2023-08

3. “DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies;Frontiers in Oncology;2023-06-28

4. Chemotherapy-Induced Oral Complications and Prophylaxis Strategies;Cancer Investigation;2023-04-20

5. Overcoming the imatinib-resistant BCR-ABL mutants with new ureidobenzothiazole chemotypes endowed with potent and broad-spectrum anticancer activity;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-03-17